Event Abstract

In vitro evaluation of bacteria growth inhibition by E. coli, S. aureus, E. faecalis

  • 1 Institute of Inorganic Chemistry and Technology, Cracow University of Technology, Poland
  • 2 Department of Chemistry and Technology of Polymers, Cracow University of Technology, Poland

Materials that contain silver nanoparticles possess strong antimicrobial properties allowing to decrease the risk of developing a wound infection. Hydroxyapatite  is naturally occurring mineral based on calcium phosphate This material has a high degree of biocompatibility, exhibits osteoconductive behavior and can promote chemical bonding between implanted material and living tissue.

The main objective of this study was estimation of the inhibition of bacterial growth on the surface of hydroxyapatite doped with variable amounts of silver nanoparticles, synthesized in situ, against bacteria such as E.coli, S. aureus and E. faecalis respectively.

This evaluation was analyzed by means of Kirby-Bauer method and was based on measurement of sensitivity of bacteria exposed to hydroxyapatite sample doped by silver nanoparticles by culturing bacteria on solid growth media surrounding sources of tested substances. Mueller Hinton agar was used as a culture medium. The density of bacterial suspensions was adjusted to 0,5 McFarland unit. 9 mm discs containing suspensions of bone substitute (100 mg/ml) were placed on agar plate. The samples were incubated for 24 h at 37˚C. Prior to analysis hydroxyapatite was obtained by calcination of bone pulp. The first sample contained pure hydroxyapatite, second hydroxyapatite modified with 1000 ppm of silver nanoparticles and third HAp with 500 ppm of AgNPs.

Table 1. Evaluation of inhibition of bacterial growth

Table 1 presents the results of measured zones of inhibition. Due to the presence of silver nanoparticles, samples 2 and 3 exhibited antibacterial activity on E. coli and S. aureus. Notably, the size of inhibition zone is determined by the concentration of silver nanoparticles. A higher  content of AgNPs lead to formation of   larger zone of inhibition. Interestingly, the E. faecalis bacteria are not sensitive to any sample.

Samples 2 and 3 showed an increased antimicrobial activity against S. Aureus leading to a decrease in viability of the bacterial strain. A sample of pure hydroxyapatite does not exhibit a strong antibacterial effect.

The results showed that the antibacterial activity of tested materials, except the pure hydroxyapatite, reached the highest values against E.coli and S. aureus. Kirby-Bauer tests revealed that the samples 2 and 3 show inhibitory activity and in the future can be used as a bone substitutes with valuable antimicrobial properties.

This work was financed by the National Centre for Research and Development under the Lider project contract no. 037/481/L-5/13/NCBR/2014

References:
[1] Ciobanu C.S., Iconaru L.S., Le Coustumer P., Nanoscale Res Lett. 2012; 7(1): 324.

Keywords: Bone Regeneration, in vitro, biomaterial, nanoparticle

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: Poster

Topic: Regeneration inducing biomaterials

Citation: Pluta K, Malina D, Tyliszczak B and Sobczak-Kupiec A (2016). In vitro evaluation of bacteria growth inhibition by E. coli, S. aureus, E. faecalis. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.00409

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.